← boothcheck

BN vs VTR stock comparison

BROOKFIELD CORPORATION vs Ventas, Inc., two REIT stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Ventas earns 2.06% on equity, Brookfield 1.95%, and both figures are near-meaningless: Ventas's healthcare-property income is buried under depreciation, Brookfield's diversified-asset earnings under mark timing. What distinguishes them is model, a focused senior-housing-and-medical-office REIT against a diversified asset owner-manager. Ventas pays a 2.16% dividend on its healthcare properties; Brookfield none listed and shows a negative free-cash figure as it deploys. Ventas shows no debt on this page, Brookfield the same. Ventas trades at 161.9 GAAP earnings, Brookfield at 84. The pair prices a healthcare REIT against a diversified compounder; Ventas offers senior-housing demographic exposure with a dividend, Brookfield capital appreciation across many asset classes, and neither should be judged on the reported returns that so badly understate both.

Comparison updated 2026-07-11.

BN vs VTR: the numbers

MetricBNVTR
Price$42.87$89.03
Market cap$96.3B$43.3B
SectorREITREIT
StageMatureGrowth
P/E84.1161.9
P/B0.583.29
P/S1.287.07
EV/EBITDA7.730.0
Revenue growth+0.7%+20.6%
Net margin4.3%4.4%
Return on equity1.9%2.1%
Return on assets0.6%1.0%
FCF yield-3.9%4.0%
Dividend yield2.2%
Debt / equity0.000.00
Altman Z (solvency)0.311.67
Piotroski F (quality)8 / 98 / 9
Full BN report → Full VTR report →
Get boothcheck's read on BN and VTR, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.